ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,564Medicare Part D Prescriptions Filled, Including Refills

Rank: 48 out of 2094

$926K Total Retail Price of All Prescriptions

Rank: 111 out of 2094

636 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 636 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

3% of this provider’s 13,715 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 946 784 1 1
METFORMIN HCL 864 699 2 8
METOPROLOL TARTRATE 791 662 3 10
AMLODIPINE BESYLATE 653 610 4 2
OMEPRAZOLE 642 527 5 4
ENALAPRIL MALEATE 469 404 6 25
IBUPROFEN 445 339 7 73
ZOLPIDEM TARTRATE 395 321 8 14
NAPROXEN 389 334 9 84
FUROSEMIDE 292 271 10 6
ATORVASTATIN CALCIUM 278 217 11 5
DIOVAN 264 240 12 13
GLIMEPIRIDE 253 194 13 31
CRESTOR 240 226 14 15
LEVOTHYROXINE SODIUM 236 208 15 3
ALENDRONATE SODIUM 236 201 15 30
GLYBURIDE-METFORMIN HCL 228 183 R 17 94
AZITHROMYCIN 224 171 18 27
CARVEDILOL 215 208 19 19
JANUVIA 214 196 20 35
NABUMETONE 195 152 21 203
CLOPIDOGREL 190 179 22 22
AMLODIPINE BESYLATE-BENAZEPRIL 187 154 23 58
NEXIUM 181 124 24 16
DIOVAN HCT 176 147 25 28
PLAVIX 151 147 26 38
NOVOLOG MIX 70-30 150 133 27 247
HYDROCHLOROTHIAZIDE 145 112 28 12
LANTUS SOLOSTAR 145 113 28 76
PROAIR HFA 140 108 30 45
PROMETHAZINE VC 133 84 R 10 31 345
LOSARTAN POTASSIUM 132 115 32 17
ONGLYZA 131 116 33 134
BETAMETHASONE DIPROPIONATE 126 101 34 202
ATELVIA 119 117 35 135
HUMALOG MIX 75-25 119 102 35 273
LEVOFLOXACIN 116 99 37 70
LANTUS 103 83 38 66
MECLIZINE HCL 102 87 39 103
CLOTRIMAZOLE-BETAMETHASONE 102 59 39 91
EVISTA 100 82 41 131
BENICAR 99 99 42 108
LACTULOSE 96 68 43 65
LOVAZA 96 44 43 53
WARFARIN SODIUM 92 92 45 11
LOSARTAN-HYDROCHLOROTHIAZIDE 89 68 46 52
INSULIN SYRINGE 88 69 47 143
LISINOPRIL 86 84 48 7
ATENOLOL 83 63 49 21
IBANDRONATE SODIUM 81 79 50 140
LIPITOR 79 74 51 39
EXFORGE 78 42 52 105
PATANOL 78 62 52 198
DIGOXIN 77 76 54 51
ZETIA 73 49 55 79
HYDROXYZINE HCL 71 50 R 56 232
VENTOLIN HFA 70 36 57 132
CIPROFLOXACIN HCL 70 54 57 81
SINGULAIR 66 39 59 64
BYSTOLIC 65 55 60 83
RAMIPRIL 63 59 61 48
CYCLOBENZAPRINE HCL 63 24 R 61 115
LYRICA 63 44 61 85
FAMOTIDINE 61 59 64 34
JANUMET 59 48 65 86
METOPROLOL SUCCINATE 57 56 66 9
ENALAPRIL-HYDROCHLOROTHIAZIDE 57 48 66 213
TRAMADOL HCL 54 27 68 33
PAROXETINE HCL 53 33 69 77
GLYBURIDE 53 53 R 69 95
ADVAIR DISKUS 53 42 69 36
LEVEMIR FLEXPEN 51 34 72 188
GABAPENTIN 51 40 72 23
METOPROLOL-HYDROCHLOROTHIAZIDE 51 50 72 327
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 1, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.